Crinetics Pharmaceuticals, Inc. (CRNX) insider trading

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Jeff E. Knight

Chief Dev. & Operating Officer

—

$3.79M (3) scheduled

−$3.79M

105,289

0.0993%

$4.21M

+100.2%

Richard Scott Struthers

President & CEO

—

$821.51K (2) scheduled

−$821.51K

111,100

0.1047%

$4.44M

−91.3%

Stephen F. Betz

Chief Scientific Officer

—

$396.61K (2) scheduled

−$396.61K

0

0.0000%

$0.00

−100.0%

Stephanie Okey

Director

—

$365.15K (3) scheduled

−$365.15K

0

0.0000%

$0.00

−100.0%

Coelho Rogerio Vivaldi

Director

—

$300.76K (3) scheduled

−$300.76K

0

0.0000%

$0.00

−100.0%

Tobin Schilke

Chief Financial & Infra. Ofcr.

—

$266.30K (1) scheduled

−$266.30K

0

0.0000%

$0.00

−100.0%

Dana Pizzuti

Chief Med and Dev Officer

—

$225.10K (1) scheduled

−$225.10K

66,837

0.0630%

$2.67M

+120.3%

Isabel Kalofonos

Chief Commercial Officer

—

$137.50K (1) scheduled

−$137.50K

0

0.0000%

$0.00

−100.0%

Wendall Wierenga

Director

—

116,146

0.1095%

$4.65M

+6.3%

Wendell Wierenga

Director

—

0

0.0000%

$0.00

−100.0%

Caren Deardorf

Director

—

0

0.0000%

$0.00

−100.0%

Matthew K Fust

Director

—

0

0.0000%

$0.00

−100.0%

Weston Nichols

Director

—

0

0.0000%

$0.00

−100.0%

Camille L Bedrosian

Director

—

0

0.0000%

$0.00

−100.0%

Crinetics Pharmaceuticals, Inc.

What the insiders did Scheduled selling only

By person